home | Citra-Lock™ | Compared with heparin
Citra-Lock™
Compared with herapin


Study Aim: To determine whether locking with citrate 30% could increase overall catheter patency and reduce catheter related infections in comparison to heparin. The secondary aim was to determine whether a difference in major bleeding episodes could be demonstrated between citrate and heparin.
Study Design: Multicentre (10 centres), double blind, randomised controlled, 291 catheters (143 heparin and 148 citrate 30%), 98 tunelled catheters, 193 non-tunelled catheters days 16.547.



Conclusion:
The use of citrate 30% for catheter locking in comparison to heparin can: